STOCK TITAN

Allstate Corp SEC Filings

ALL NYSE

Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Allstate’s 10-K can exceed 300 pages of loss triangles, catastrophe risk tables, and actuarial jargon—enough to overwhelm even seasoned analysts. If you are digging for Allstate insider trading Form 4 transactions before earnings or trying to trace reserve changes buried deep in footnotes, the search can feel endless.

Stock Titan solves that problem. Our AI reads every Allstate quarterly earnings report 10-Q filing, flags segment profitability swings, and delivers Allstate Form 4 insider transactions real-time to your dashboard. Get Allstate SEC filings explained simply; each note is paired with bite-sized context so you can move from raw document to Allstate earnings report filing analysis in minutes. Interactive filters help in understanding Allstate SEC documents with AI, highlighting where catastrophe losses hit income, how investment gains flow through results, and which geographies drive combined ratios.

Need governance details? Drill into the Allstate annual report 10-K simplified section for reserve adequacy discussions, open the Allstate proxy statement executive compensation snapshot to see incentive structures, or track risk disclosures through Allstate 8-K material events explained. Professional investors monitor Allstate executive stock transactions Form 4 alongside claim-severity trends; our platform puts both in one place, updated the moment EDGAR posts. Save hours, surface the metrics that move the stock, and make better decisions with AI-powered clarity.

Rhea-AI Summary

Allstate Corporation Chairman, President & CEO Thomas J. Wilson reported several internal transfers of Allstate common stock involving his personal trusts and direct ownership. On December 19, 2025, 61,308 shares previously held by the Thomas J. Wilson 2023-B GRAT Trust were distributed to his direct ownership, and 50,134 shares from the same 2023-B GRAT were transferred to the Thomas J. Wilson 2020 GRAT Remainder Trust at a reported price of $0 per share.

The filing also notes a distribution of 33,421 shares from the Thomas J. Wilson 2024-C GRAT Trust to direct ownership on the same date. After receiving these shares, he contributed a total of 94,729 shares to the Thomas J. Wilson 2025-E GRAT Trust. Following these moves, he continues to hold Allstate stock directly and indirectly through multiple GRATs and a 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Allstate Corporation furnished a Regulation FD report to provide access to its November 2025 monthly release on estimated catastrophe losses and policies in force.

The company states that this release is posted on allstateinvestors.com and is attached as Exhibit 99, a press release dated December 18, 2025 that is furnished, not filed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
current report
-
Rhea-AI Summary

The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open-market sales of Allstate common stock and related option movements. On December 15, 2025, he sold Allstate shares in several transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share under a Rule 10b5-1 trading plan adopted on June 27, 2025.

After these sales, he directly owned 128,005.491 Allstate shares, with additional indirect holdings through multiple GRATs, a 401(k) plan and trusts. The filing also lists employee stock options with exercise prices of $122.64, $137.10 and $159.17 per share, some of which were transferred on December 12, 2025 to TJW Options LLC series entities, while other option tranches remain directly held and vest in increments through 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open‑market sales of company stock. On 12/01/2025, he sold 12,603 shares of Allstate common stock at a weighted average price of $212.4797, with individual sale prices ranging from $212.040 to $213.025. The same day, he sold another 4,204 shares at a weighted average price of $213.2706, with trades between $213.060 and $213.530. These transactions were carried out under a Rule 10b5‑1 trading plan adopted on June 27, 2025. After these sales, Wilson directly holds 144,812.491 shares of Allstate common stock and also reports additional indirect ownership through several GRATs, a 401(k) plan, and a remainder trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Allstate Corporation executive reports option exercises and share sales. President, Enterprise Solutions Suren Gupta exercised employee stock options to buy 750 shares of Allstate common stock at $62.32 per share on 11/26/2025 and 3,786 shares at the same exercise price on 11/28/2025. On each date, he sold the same number of shares in open-market transactions at weighted average prices of $215.0083 and $215.1334, respectively, under a Rule 10b5-1(c) trading plan adopted on June 9, 2025.

After these transactions, Gupta directly beneficially owns 100,646 Allstate shares, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC. He also holds 19,593 remaining employee stock options with a $62.32 exercise price expiring on 02/11/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

A holder has filed a Form 144 notice to potentially sell 33,614 shares of common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $7,058,940. The issuer has 261,681,708 shares outstanding, providing context for the size of this planned sale.

The shares to be sold were originally acquired from the issuer as compensation via performance awards on February 22, 2018 (30,113 shares) and February 21, 2012 (3,501 shares), with payment in the form of compensation rather than cash. The seller, identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15, has also sold four prior 16,807‑share blocks of common stock in the past three months, each generating multi‑million‑dollar gross proceeds, and represents that it is not aware of undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Allstate insider plans additional stock sale under Rule 144

A holder of Allstate common stock has filed a Form 144 indicating an intention to sell 3,786 shares through Fidelity Brokerage Services on the NYSE. The planned sale, dated 11/28/2025, relates to shares acquired the same day via an option granted on 02/11/2016 and paid for in cash. The filing notes 261,681,708 Allstate common shares outstanding, giving context for the size of this transaction.

Over the prior three months, the same seller, Suren K. Gupta, reported multiple open‑market sales of Allstate common stock, including 1,400 shares on 11/14/2025, 400 shares on 11/17/2025, 21,871 shares on 11/21/2025, 600 shares on 11/24/2025, and 750 shares on 11/26/2025, with disclosed gross proceeds for each trade. The signer represents that they are not aware of undisclosed material adverse information about Allstate when making or planning these sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

The Allstate Corporation executive files Form 4 for option exercise and share sale. On 11/24/2025, the President, Enterprise Solutions of Allstate exercised employee stock options for 600 shares of common stock at an exercise price of $62.32 per share and then sold 600 shares of common stock in an open-market transaction at a weighted average price of $215.0175 per share. These trades were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. Following the transactions, the reporting person beneficially owned 100,646 shares directly, 1,329 shares through a 401(k) plan, 7 shares through VVG Holdings LLC, and 24,129 employee stock options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Allstate Corporation (ALL) reported an insider equity transaction by its President, Enterprise Solutions, Suren Gupta. On 11/21/2025, he exercised an employee stock option for 21,871 shares of common stock at an exercise price of $62.32 per share and, on the same date, sold 21,871 shares of common stock in an open-market transaction at a weighted average price of $215.2125 per share.

The transactions were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. After these transactions, he beneficially owned 100,646 shares of Allstate common stock directly, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC, as reported in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Allstate Corporation has filed a Form S-8 to register deferred compensation obligations issued under its Deferred Compensation Plan for Independent Contractor Exclusive Agents. The plan allows eligible exclusive insurance agents and exclusive financial specialists, who are compensated as independent contractors by Allstate subsidiaries, to defer portions of their compensation.

Deferred amounts are recorded by book entry in notional accounts and allocated among investment options chosen by participants, currently mirroring certain options in the Allstate 401(k) Savings Plan, for accounting purposes only. The obligations are unfunded, unsecured general obligations of Allstate, ranking equally with its other unsecured and unsubordinated indebtedness and payable in U.S. dollars, so participants are exposed to Allstate’s general credit risk.

The plan restricts early distributions to limited circumstances such as separation from service, hardship or unforeseeable financial emergency under specified tax rules, certain in-service withdrawals, or plan termination. Allstate may amend or terminate the plan, but cannot reduce previously deferred compensation or related accruals. The filing also outlines existing Delaware-law based indemnification protections and insurance coverage for directors and officers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

What is the current stock price of Allstate (ALL)?

The current stock price of Allstate (ALL) is $207.8 as of December 26, 2025.

What is the market cap of Allstate (ALL)?

The market cap of Allstate (ALL) is approximately 54.7B.
Allstate Corp

NYSE:ALL

ALL Rankings

ALL Stock Data

54.70B
260.16M
0.59%
81.62%
1.54%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
NORTHBROOK